Full Length Research Paper
References
|
Aboagye-Antwi F, Kwansa-Bentum B, Dadzie SK, Ahorlu CK, Appawu MA, Gyapong J, Wilson MD, Boakye DA (2015). Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana. Parasit. Vect. 8(1):562. |
|
|
Addiss DG, Dimock KA, Eberhard ML, Lammie PJ (1995). Clinical, parasitologic, and immunologic observations of patients with hydrocele and elephantiasis in an area with endemic lymphatic filariasis. J. Infect. Dis. 171(3):755-758. |
|
|
Anosike JC, Nwoke BE, Ajayi EG, Onwuliri CO, Okoro OU, Oku EE, Asor JE, Amajuoyi OU, Ikpeama CA, Ogbusu FI, Meribe CO (2005). Lymphatic filariasis among Ezza people of Ebonyi State Eastern Nigerian. Ann. Agric. Environ. Med. 12:181-186. |
|
|
Bockarie MJ, Taylor MJ, Gyapong JO (2009). Current practices in the management of lymphatic filariasis Comprehensive review of the preventive chemotherapy strategy for LF. Expert. Rev. Anti. Infect. Ther. 7(5):595-605. |
|
|
Cheesbrough M (2005). District laboratory practice in tropical countries. Cambridge University Press. |
|
|
Coulibaly YI, Dembele B, Diallo AA, Konate S, Dolo H, Coulibaly SY, Doumbia SS, Soumaoro L, Coulibaly ME, Bockarie MJ, Molyneux D, Nutman TB, Klion AD, Toure YT, Traore SF (2015). The Impact of Six Annual Rounds of Mass Drug Administration on Wuchereria bancrofti Infections in Humans and in Mosquitoes in Mali. Am. J. Trop. Med. Hyg. 93 (2):356-360. |
|
|
Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA (2005). Treatment strategies underpinning the Global Programme to Eliminate Lymphatic Filariasis. Expert Opin. Pharmacother. 6(2):179-200 |
|
|
Hafiz I, Graves P, Hag R, Flora M, Kelly-Hope LA (2015). Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration. Trans. R. Soc. Trop. Med. Hyg. 109(11):700-709. |
|
|
Iboh CI, Okon OE, Opara KN, Asor JE, Etim SE (2012). Lymphatic filariasis among the Yakurr people of Cross River State, Nigeria. Parasit.Vect. 5:203.Crossref |
|
|
King JD, Eigege A, Umaru J, Jip N, Miri E, Jiya J, Alphonsus KM, Sambo Y, Graves P, Richards F (2012). Evidence for Stopping Mass Drug Administration for Lymphatic Filariasis in Some, But Not All Local Government Areas of Plateau and Nasarawa States, Nigeria. Am. J. Trop. Med. Hyg. 87(2):272-280. |
|
|
Mbah DC, Njoku OO (2002). Prevalence of lymphatic filariasis (LF) in Ovari, Aguata Local Government Area of Anambra State, Nigeria. Nigerian. J. Parasitol. 21:95-102. |
|
|
Okon OE, Iboh CI, Opara KN (2010). Bancrofti anfilariasis among the Mbembe people of Cross River State, Nigeria. J. Vect. Borne. Dis. 47(2):91-96. |
|
|
Ottesen EA, Duke BOL, Karam M, Behbehani K (1997). Strategies and tools for the control/elimination of lymphatic filariasis. Bull. World Health Organ.75 (6):491-503. |
|
|
Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Elaziz KM, Farid HA, Shannon WD, Weil GJ (2006). Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancrofti anfilariasis in Egypt: a comprehensive assessment. Lancet 367(9515):992-999. |
|
|
Richards FO, Eigege A, Miri ES, Kal A, Umaru J, Pam D, Rakers LJ, Sambo Y, Danboyi J, Ibrahim B, Adelamo SE (2011). Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria. PLoS. Negl. Trop. Dis. 5(10):1346. |
|
|
Sasa M (1976). Human filariasis. A global survey of epidemiology and control: University Park Press, Baltimore. |
|
|
Simonsen PE, Derua YA, Kisinza WN, Magesa SM, Malecela MN, Pedersen EM (2013). Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission. BMC. Infect. Dis. 13:335. |
|
|
Simonsen PE, Niemann L, Meyrowitsch DW (1997). Wuchereria bancrofti in Tanzania: microfilarial periodicity and effect of blood sampling time on microfilarial intensities. Trop. Med. Int. Health. 2:153-158. |
|
|
Sodahlon YK, Dorkenoo AM, Morgah K, Nabiliou K, Agbo K, Miller R, Datagni M, Seim A, Mathieu E (2013). A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation. PLoS. Negl. Trop. Dis. 7(4):121-125 |
|
|
Stolk WA, Van Oortmarssen GJ, Pani SP, De Vlas SJ, Subramanian S, Das PK, Habbema JD(2005). Effects of Ivermectin and Diethylcarbamazine on Microfilariae and Overall Microfilaria Production in Bancroftian Filariasis. Am. J. Trop. Med. Hyg. 73(5):881-887. |
|
|
Taylor MJ, Hoerauf A, Bockarie M (2010). Lymphatic filariasis and onchocerciasis : An up-to-date review of the epidemiology and treatment strategies for lymphatic filariasis (LF) and onchocerciasis. Lancet 376(9747):1175-1185. |
|
|
Udoidung NI, Braide IE, Opara KN, Atting IA, Adie H (2008). Currentstatus of Bancrofti anfilariasis in rural communities of the Lower Cross River Basin, Nigeria. Parasitological and Clinical aspects. J. Publ. Health 16:383-388. |
|
|
World Health Organization (WHO) (1991). Basic laboratory methods in medical parasitology. World Health Organization, Geneva. P 69. |
|
|
World Health Organization (WHO) (1995). The world health report: bridging the gaps. Geneva. P 123. |
|
|
World Health Organization (WHO) (1997). Elimination of lymphatic filariasis as a public health problem - resolution of the executive board of the WHO (WHA50.29). Geneva: Fiftieth World Health. Assembly. |
|
|
World Health Organization (WHO) (2005). Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. WHO/CDS/CPE/CEE/2005.50. |
|
|
World Health Organization (WHO) (2010). Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: half way towards eliminating lymphatic filariasis. WHO /HTM/ NTD/ PCT/ 2010. P 6. |
|
|
World Health Organization (WHO) (2012). Report of ninth workshop for filariasis programme managers. Bamako, Mali, 10-14 may 2010, Available at : http://www.afro.who.int/index.php?option=com_docman&task=doc_download&gid=7650&Itemid |
|
|
World Health Organization (WHO) (2013b). Lymphatic filariasis. Available at: http://www.who.int/mediacentre/factsheets/fs102/en/#. |
|
|
World Health Organization (WHO) (2013c). Global Programme to Eliminate Lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration. A manual for national elimination programmes. Geneva: World Health Organization. Report No: WHO/HTM/NTD/PCT/2011.4. |
|
|
World Health Organization (WHO) (2015).Global programme to eliminate lymphatic filariasis: Progress report in 2014. Wkly. Epidemiol. Rec. 90(38):489-504 |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
